TROP-2-targeted anti-CD74 siRNA (Immunomedics)

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameTROP-2-targeted anti-CD74 siRNA (Immunomedics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate

Mechanisms of ActionHLA-DR antigens-associated invariant chain inhibitorsTumor-associated calcium signal transducer 2 modulators

TargetsTumor-associated calcium signal transducer 2HLA-DR antigens-associated invariant chain

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunomedics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A